Weiss Asset Management LP acquired a new position in shares of Trupanion, Inc. (NASDAQ:TRUP - Free Report) in the third quarter, according to its most recent filing with the Securities & Exchange Commission. The firm acquired 20,360 shares of the financial services provider's stock, valued at approximately $855,000.
A number of other hedge funds have also modified their holdings of TRUP. FMR LLC grew its stake in Trupanion by 55,963.7% in the third quarter. FMR LLC now owns 1,172,293 shares of the financial services provider's stock valued at $49,213,000 after purchasing an additional 1,170,202 shares in the last quarter. Marshall Wace LLP grew its stake in Trupanion by 11.9% in the second quarter. Marshall Wace LLP now owns 1,094,589 shares of the financial services provider's stock valued at $32,181,000 after purchasing an additional 116,496 shares in the last quarter. Renaissance Technologies LLC bought a new position in Trupanion in the second quarter valued at approximately $4,739,000. Dimensional Fund Advisors LP grew its stake in Trupanion by 24.3% in the second quarter. Dimensional Fund Advisors LP now owns 137,833 shares of the financial services provider's stock valued at $4,052,000 after purchasing an additional 26,941 shares in the last quarter. Finally, BNP Paribas Financial Markets boosted its stake in shares of Trupanion by 7.6% during the 3rd quarter. BNP Paribas Financial Markets now owns 124,548 shares of the financial services provider's stock worth $5,229,000 after acquiring an additional 8,781 shares during the period.
Analyst Ratings Changes
Several brokerages have recently commented on TRUP. Northland Securities lifted their target price on Trupanion from $45.00 to $50.00 and gave the stock a "market perform" rating in a research note on Thursday, October 31st. Stifel Nicolaus lifted their target price on Trupanion from $30.00 to $40.00 and gave the stock a "hold" rating in a research note on Monday, September 23rd. Piper Sandler lifted their price target on Trupanion from $45.00 to $57.00 and gave the stock a "neutral" rating in a report on Thursday, October 31st. Finally, Bank of America lifted their price target on Trupanion from $47.00 to $56.00 and gave the stock a "buy" rating in a report on Friday, September 20th. Three investment analysts have rated the stock with a hold rating, three have assigned a buy rating and one has issued a strong buy rating to the company's stock. Based on data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus target price of $44.67.
Check Out Our Latest Research Report on Trupanion
Insider Buying and Selling at Trupanion
In other news, Director Murray B. Low sold 2,000 shares of Trupanion stock in a transaction on Wednesday, November 6th. The stock was sold at an average price of $52.67, for a total value of $105,340.00. Following the transaction, the director now owns 131,513 shares in the company, valued at approximately $6,926,789.71. This trade represents a 1.50 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CFO Fawwad Qureshi sold 622 shares of Trupanion stock in a transaction on Tuesday, November 26th. The shares were sold at an average price of $52.61, for a total value of $32,723.42. Following the completion of the transaction, the chief financial officer now owns 9,867 shares in the company, valued at approximately $519,102.87. The trade was a 5.93 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 28,405 shares of company stock valued at $1,512,482 in the last three months. Corporate insiders own 5.50% of the company's stock.
Trupanion Trading Up 4.8 %
NASDAQ TRUP traded up $2.55 during midday trading on Monday, hitting $56.01. The company had a trading volume of 619,463 shares, compared to its average volume of 673,349. The company has a debt-to-equity ratio of 0.40, a current ratio of 1.66 and a quick ratio of 1.66. The firm has a 50-day moving average price of $51.08 and a 200-day moving average price of $41.19. Trupanion, Inc. has a twelve month low of $19.69 and a twelve month high of $57.90.
Trupanion (NASDAQ:TRUP - Get Free Report) last announced its quarterly earnings data on Wednesday, October 30th. The financial services provider reported $0.03 earnings per share for the quarter, beating the consensus estimate of ($0.06) by $0.09. The firm had revenue of $327.50 million during the quarter, compared to analysts' expectations of $321.79 million. Trupanion had a negative return on equity of 4.36% and a negative net margin of 1.08%. The company's quarterly revenue was up 14.6% compared to the same quarter last year. During the same period in the previous year, the firm earned ($0.10) EPS. On average, analysts expect that Trupanion, Inc. will post -0.23 EPS for the current fiscal year.
About Trupanion
(
Free Report)
Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.
Further Reading
Before you consider Trupanion, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Trupanion wasn't on the list.
While Trupanion currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.